These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9516674)

  • 21. [Acute intermittent porphyria].
    Sugimura K
    Nihon Rinsho; 1995 Jun; 53(6):1418-21. PubMed ID: 7616656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helper-dependent adenoviral liver gene therapy protects against induced attacks and corrects protein folding stress in acute intermittent porphyria mice.
    Unzu C; Sampedro A; Mauleón I; González-Aparicio M; Enríquez de Salamanca R; Prieto J; Aragón T; Fontanellas A
    Hum Mol Genet; 2013 Jul; 22(14):2929-40. PubMed ID: 23562909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute porphyrias in the Argentinean population: a review.
    Parera VE; De Siervi A; Varela L; Rossetti MV; Batlle AM
    Cell Mol Biol (Noisy-le-grand); 2003 Jun; 49(4):493-500. PubMed ID: 12899439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anesthesia in a child with homozygous porphobilinogen deaminase deficiency: a severe form of acute intermittent porphyria.
    Sheppard L; Dorman T
    Paediatr Anaesth; 2005 May; 15(5):426-8. PubMed ID: 15828996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acute intermittent porphyria associated with hyperaldosteronism and inappropriate antidiuretic hormone secretion syndrome].
    Frère T; Roy-Peaud F; Ripault MP; Dumas P; Silvain C; Pourrat O; Beauchant M
    Gastroenterol Clin Biol; 1998; 22(8-9):727-31. PubMed ID: 9823563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between biochemical findings, structural and enzymatic abnormalities in mutated HMBS identified in six Israeli families with acute intermittent porphyria.
    Ulbrichova D; Schneider-Yin X; Mamet R; Saudek V; Martasek P; Minder EI; Schoenfeld N
    Blood Cells Mol Dis; 2009; 42(2):167-73. PubMed ID: 19138865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Porphobilinogen deaminase gene structure and molecular defects.
    Deybach JC; Puy H
    J Bioenerg Biomembr; 1995 Apr; 27(2):197-205. PubMed ID: 7592566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks.
    Sardh E; Harper P; Andersson DE; Floderus Y
    Eur J Intern Med; 2009 Mar; 20(2):201-7. PubMed ID: 19327613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute intermittent porphyria: psychosis as the only clinical manifestation.
    Ellencweig N; Schoenfeld N; Zemishlany Z
    Isr J Psychiatry Relat Sci; 2006; 43(1):52-6. PubMed ID: 16910386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion.
    Sardh E; Rejkjaer L; Andersson DE; Harper P
    Clin Pharmacokinet; 2007; 46(4):335-49. PubMed ID: 17375984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocellular carcinoma in patients from northern Sweden with acute intermittent porphyria: morphology and mutations.
    Bjersing L; Andersson C; Lithner F
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):393-7. PubMed ID: 9162306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic strategy, genetic diagnosis and identification of new mutations in intermittent porphyria by denaturing gradient gel electrophoresis.
    Nissen H; Petersen NE; Mustajoki S; Hansen TS; Mustajoki P; Kauppinen R; Hørder M
    Hum Mutat; 1997; 9(2):122-30. PubMed ID: 9067752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haem precursors and porphobilinogen deaminase in erythrocytes and lymphocytes of patients with acute intermittent porphyria.
    Gross U; Jacob K; Frank M; Doss MO
    Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):29-35. PubMed ID: 9074786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocyte transplantation ameliorates the metabolic abnormality in a mouse model of acute intermittent porphyria.
    Yin Z; Wahlin S; Ellis EC; Harper P; Ericzon BG; Nowak G
    Cell Transplant; 2014; 23(9):1153-62. PubMed ID: 23582197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. De Novo mutation found in the porphobilinogen deaminase gene in Slovak acute intermittent porphyria patient: molecular biochemical study.
    Ulbrichova D; Flachsova E; Hrdinka M; Saligova J; Bazar J; Raman CS; Martasek P
    Physiol Res; 2006; 55 Suppl 2():S145-154. PubMed ID: 17298218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of acute intermittent porphyria].
    Nielsen KR
    Ugeskr Laeger; 1997 Feb; 159(7):960-1. PubMed ID: 9054089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenoviral-mediated expression of porphobilinogen deaminase in liver restores the metabolic defect in a mouse model of acute intermittent porphyria.
    Johansson A; Nowak G; Möller C; Blomberg P; Harper P
    Mol Ther; 2004 Aug; 10(2):337-43. PubMed ID: 15294180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A family with acute intermittent porphyria.
    Billoo AG; Lone SW
    J Coll Physicians Surg Pak; 2008 May; 18(5):316-8. PubMed ID: 18541093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of acute intermittent porphyria carriers by molecular biologic methods.
    Bor M; Balogh K; Pusztai A; Tasnádi G; Hunyady L
    Acta Physiol Hung; 1999; 86(2):147-53. PubMed ID: 10741873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New mutations of the hydroxymethylbilane synthase gene in German patients with acute intermittent porphyria.
    Gross U; Puy H; Doss M; Robreau AM; Nordmann Y; Doss MO; Deybach JC
    Mol Cell Probes; 1999 Dec; 13(6):443-7. PubMed ID: 10657149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.